Abstract
The neuregulins Neuregulins, a family of EGF-like signaling molecules, are involved in cell-cell crosstalk and play an important role in development, maintenance and repair of the nervous system, heart, breast and other organs. Independent studies described a ligand for the oncogene ErbB2 (neu, Her2) and factors that stimulated proliferation of Schwann cells, as well as synthesis of receptors for acetylcholine by muscle. These ligands and factors are essentially products of the same gene, referred to by Marchionni M. as neuregulin (NRG-1) [1]. Besides NRG-1 gene, there are other genes that encode related proteins, such as NRG-2 (Don-1, NTAK), NRG-3 and NRG-4. There are few studies that describe NRG-2, −3 and −4 and a complete analysis of their function remains a challenge. However, NRG-2 was recently reported as a component of stress granules (SG), microscopically visible aggregates of translationally stalled messenger ribonucleoprotein complexes that are formed in response to direct stress conditions [2]. Furthermore, it was shown that NRG-2, secreted from astrocytes, bound to ErbB3 on neurons and promoted neuronal survival [3]. NRG-3 was shown to be associated with schizophrenia (SZ) in a Chinese population [4], with bipolar disorder (BD) [5] and with the risk and age of onset of Alzheimer disease (AD) [6]. In addition, NRG-3 has a key function in promoting early mammary morphogenesis and is involved in breast cancer (BC) [7]. NRG-4 expression was decreased in human inflammatory bowel disease samples and mouse models of colitis, suggesting that activation of ErbB4 is altered [8]. An interesting study [9] showed that NRG-4 overexpression prevents high fat diet-induced weight gain and fatty liver and reduces obesity-induced chronic inflammation. Considering the increasing interest and research focused on NRG-1 in the past years, this review summarizes what is currently known about NRG-1 and its impact on health and disease as well as its current and potential use(s) as a CNS anti-inflammatory agent against inducers of brain inflammation and injury as well as in the treatment of various neurological disorders. Neuregulin-1: Structure, function and signaling pathways: NRG-1 gene encodes 21 exons located on human chromosome 8p22–21. Alternative splicing of more than 30 exons in different parts of the NRG-1 transcript generates more than 30 isoforms that can be grouped into six types (I-VI) [10–12] (Figure 1). They are synthesized as transmembrane precursors consisting of either an immunoglobulin-like (Ig) domain or cysteine-rich domain (CRD), an EGF-like domain, a transmembrane domain and a cytoplasmic tail [13]. NRG-1 types I and II are released from the cell surface after protease-mediated proteolytic cleavage and may function as paracrine signals [14]. NRG-1 type III remains tethered to the cell membrane after cleavage and acts as a juxtacrine signal [15]. Full-length type IV spans 1.8 kb and encodes a putative protein of 590 amino acids with a predicted molecular mass of approximately 66 kDa [15]. Further-more, there are two major classes of NRG-1 identified as α and β isoforms. NRG-1α and NRG-1β contain related, but structurally distinct EGF-like domains composed of a common amino terminal segment followed by α or β variant sequences [16]. NRG-1β isoforms predominate in the nervous system while α isoforms are common in mesenchymal cells and are critically important for breast development [14]. Type I NRGα and β isoforms are the predominant isoforms expressed in early embryogenesis, whereas type II and type III are undetectable until the mid-gestation stage [17]. Type I or Heregulin is an acetylcholine receptor activator, type II is a Glial Growth Factor, type III is a sensory and motor neuron-derived factor and type IV is involved in neuronal activity regulation. Functions of types V and VI are not well known and their investigation remains a challenge. Types I, II and III of NRG-1 express in human peripheral blood in addition to neurons, while types IV and V express specifically in the brain [18]. Open in a separate window Figure 1: Neuregulin (NRG) and ErbB receptor structures. NRG gene products share a structural characteristic for the extracellular epidermal growth factor (EGF) domain and it differentiates this subfamily from other members of the EGF family. All EGF family members are ligands of ErbB receptors, although with varying affinities, with ErbB3 and ErbB4 being specific NRG-binding receptors. NRG-1 isoforms have been classified in types I-VI on the basis of differences in the NH2-terminal distal region [19].
Highlights
The neuregulinsNeuregulins, a family of epidermal growth factor (EGF)-like signaling molecules, are involved in cell-cell crosstalk and play an important role in development, maintenance and repair of the nervous system, heart, breast and other organs
We recently showed that NRG-1 protects human brain microvascular endothelial cells and astrocytes from cell death induced by CXCL10 and heme in vitro [21,22] In addition, NRG-1 improved heme-disrupted blood brain barrier (BBB) integrity in an in vitro BBB model consisting of Human Brain Microvascular Endothelial Cell (hCMEC)/D3 and human astrocytes
NRG-1 plays a protective role during development and adult life, its effects in disease vary
Summary
AD: Alzheimer Disease; AIS: Acute Ischemic Stroke; ASD: Autism Spectrum Disorder; BBB: Blood Brain Barrier; BC: Breast Cancer; BD: Bipolar Disease; CCI: Controlled Cortical Impact; CM: Cerebral Malaria; cMLCK: Cardiac Myosin Light Chain Kinase; CNS: Central Nervous System; CRD: Cysteine-rich Domain; CSC: Cancer Stem Cell; ECM: Experimental Cerebral Malaria; EGF: Epidermal Growth Factor; hCMEC: Human Brain Microvascular Endothelial Cell; HIV: Human Immunodeficiency Virus; IG: Immunoglobulin; IL: Interleukin; iPSC: Induced Pluripotent Stem Cell; iRBC: Infected Red Blood Cell; JAG1: Jagged 1; KDa: Kilo-Daltons; LOAD: Late Onset Alzheimer’s Dementia; MAP: Mitogen-activated protein; ND: Neuropsychiatric Disorders; NMDA: N-methyl-D-aspartate; NRG: Neuregulin; NTAK: Neural and Thymus-Derived Activator for ErbB Kinases; OGD: Oxygen Glucose Depravation; OPC: Oligodendrocyte Progenitor Cells; PI3-K: Phosphatidyl-Inositol-3-Kinase; PIMs: Pro-inflammatory Markers; pMCAO: Permanent Middle Cerebral Artery Occlusion; RBC: Red Blood Cell; RNA: Ribose Nucleic Acid; SERCA2a: Sarco/Endoplasmic Reticulum Ca2+ ATPase 2a; SG: Stress Granules; STAT3: Signal Transducer and Activator of Transcription 3; SZ: Schizophrenia; TBI: Traumatic Brain Injury; USD: United States Dollar
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International journal of brain disorders and treatment
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.